| Literature DB >> 31585540 |
Søren Valgreen Knudsen1,2, Henrik Vitus Bering Laursen3, Søren Paaske Johnsen4, Paul Daniel Bartels5, Lars Holger Ehlers3, Jan Mainz4,6,7,8.
Abstract
BACKGROUND: The Plan-Do-Study-Act (PDSA) method is widely used in quality improvement (QI) strategies. However, previous studies have indicated that methodological problems are frequent in PDSA-based QI projects. Furthermore, it has been difficult to establish an association between the use of PDSA and improvements in clinical practices and patient outcomes. The aim of this systematic review was to examine whether recently published PDSA-based QI projects show self-reported effects and are conducted according to key features of the method.Entities:
Keywords: Health services research; PDSA; Plan-do-study-act; Quality; Quality improvement
Mesh:
Year: 2019 PMID: 31585540 PMCID: PMC6778385 DOI: 10.1186/s12913-019-4482-6
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Fig. 1Plan-Do-Study-Act (PDSA) based quality improvement. Each cycle informs the subsequent cycle. Ideally, the complexity and size of the intervention is upscaled iteratively as time pass, knowledge is gained and quality of care is improved
Framework based on key features of data-driven PDSA projects
| Feature | Description of feature | Criteria for key feature | Supplementary features |
|---|---|---|---|
| Documentation | Sufficient documentation of PDSA cycles is set as a requirement for the project to be analysed against the full framework | Individual cycles being described, with or without details on stages within cycles | |
| Iterative cycles | The iterative approach essentially is the linking of knowledge gained from one PDSA cycle to the next. Through multiple cycles knowledge is built and interventions are either adopted, adapted or abandoned. | At least two successive cycles, linked by theme and function, in which lessons from one cycle informed the next | - Nature of cycles - Several tests of change in a cycle |
| Small-scale testing | Small tests of change allow unexpected obstacles and unforeseen effects to be caught, and trust in the project to be built before full-scale implementation. | The change(s) were introduced on a scale smaller than an entire department/treatment unit tested, before a full-scale test was begun | - Scope of QI effort - Pre-project intention of testing under different conditions - Type of scaling when using small scale |
| Continuous data collection | Using continuous data collection is necessary to understand the inherent variation within the system and determine whether the process is stable. | Data was collected regularly over time, with three or more consecutive data points | - Main type of data used - Measurement type - Use of baseline - Type of time series diagram |
| Theoretical rationale | Improvers always use theories when developing and executing their projects, but stating them can help both in designing, executing and especially evaluating it, and helps in articulation of assumptions and predictions of why the project will result in improvement in their context | Informal or formal frameworks, models, concepts and/or theories used to explain the problem, any reasons or assumptions that were used to develop the project(s) and reasons why the project(s) was expected to work | - Evidence based inspiration for the need for improvement - Origin of inspiration for QI intervention |
Fig. 2PRISMA diagram
Overview of self-reported effects, general characteristics and supplementary features of the included projects
| Self-reported effects of QI project | 27% | 32/120 | Quantitative aim was achieved | |
| 57% | 68/120 | Positive change - no quantitative aim | ||
| 15% | 18/120 | Positive change - quantitative aim not reached | ||
| 2% | 2/120 | No quantitative aim and no improvement | ||
| Included projects ( | ||||
| General characteristics | Journal | 44% | 53/120 | BMJ Quality Improvement Reports |
| 5% | 6/120 | Pediatrics | ||
| 4% | 5/120 | Journal of Oncology Practice | ||
| 47% | 56/120 | Other journals | ||
| Country | 43% | 52/120 | USA | |
| 36% | 43/120 | The UK | ||
| 5% | 6/120 | Canada | ||
| 4% | 5/120 | Singapore | ||
| 3% | 4/120 | Saudi Arabia | ||
| 2% | 2/120 | Australia | ||
| 7% | 8/120 | Other | ||
| Reach | 86% | 103/120 | Local | |
| 11% | 13/120 | Regional | ||
| 3% | 3/120 | Nationwide | ||
| 1% | 1/120 | Not stated | ||
| Area of healthcare | 57% | 68/120 | Department | |
| 30% | 36/120 | Hospital-wide | ||
| 13% | 16/120 | Other | ||
| Department specialty | 30% | 28/94 | Pediatrics | |
| 14% | 13/94 | ICU/ED | ||
| 13% | 12/94 | Surgery | ||
| 12% | 11/94 | Psychiatry | ||
| 11% | 10/94 | Internal Medicine | ||
| 21% | 20/94 | Other | ||
| Supporting framework | 58% | 70/120 | Not stated | |
| 33% | 40/120 | Model for Improvement | ||
| 9% | 11/120 | Lean, Six-sigma or other frameworks | ||
| Documentation of PDSA cycles | Documentation category | 19% | 23/120 | No details of cycles |
| 21% | 25/120 | Themes of cycles but no additional details | ||
| 50% | 60/120 | Details of individual cycles but not stages of cycles | ||
| 10% | 12/120 | Details of cycles including separate information on stages of cycles | ||
| Included projects ( | ||||
| Iterative approach characteristics | Nature of cycles | 3% | 2/72 | Single isolated cycle |
| 18% | 13/72 | Multiple isolated cycles | ||
| 57% | 41/72 | Iterative chain | ||
| 5% | 4/72 | Multiple chains of isolated cycles | ||
| 17% | 12/72 | Mix of iterative chains and isolated cycles | ||
| Several tests of change in a cycle | 76% | 55/72 | Yes | |
| 24% | 17/72 | No | ||
| Small scale testing characteristics | Scope of QI effort | 40% | 29/72 | Testing |
| 46% | 33/72 | Implementing | ||
| 0% | 0/72 | Spreading | ||
| 13% | 9/72 | Testing and implementing | ||
| 1% | 1/72 | Testing, implementing and spreading | ||
| Pre-project intention of testing under different conditions | 0% | 0/72 | Yes | |
| 100% | 72/72 | No | ||
| Type of scaling when using small scale | 10% | 1/10 | Unclear | |
| 70% | 7/10 | Increasing | ||
| 20% | 2/10 | Non-increasing | ||
| Continuous data collection characteristics | Main type of data used | 72% | 52/72 | Quantitative data |
| 22% | 16/72 | Quantitative data with supplementary qualitative data | ||
| 4% | 3/72 | Quantitative & qualitative data | ||
| 1% | 1/72 | Quantitative data but not presented | ||
| Measurement type | 67% | 48/72 | Regular three or more data points | |
| 25% | 18/72 | Before and after or per PDSA cycle(s) | ||
| 7% | 5/72 | Single data point after PDSA cycle(s) | ||
| 1% | 1/72 | No quantitative data reported | ||
| Use of baseline | 90% | 65/72 | Yes | |
| 10% | 7/72 | No | ||
| Type of time series diagram | 50% | 24/48 | Run Chart | |
| 50% | 24/48 | Control Chart | ||
| Theoretical rationale characteristics | Evidence based inspiration for the need for improvement | 94% | 68/72 | Yes |
| 6% | 4/72 | No | ||
| Origin of inspiration for QI intervention | 36% | 26/72 | External knowledge, scientific literature, previous QI or benchmarking | |
| 29% | 21/72 | Internally developed knowledge, logical thinking | ||
| 14% | 10/72 | A combination of internal and external | ||
| 21% | 15/72 | Not stated | ||
Fig. 3a) Bar-chart depicting how often the four key features were used across the projects. b) Bar-chart depicting the number of projects, which had used zero to four key features